Related by context. Frequent words. (Click for all words.) 73 Dasatinib 71 Zolinza 69 Vandetanib 68 Epratuzumab 68 Erlotinib 68 BAY #-# 68 Mipomersen 67 Laquinimod 67 angiogenesis inhibitor 67 Nexavar ® 67 proteasome inhibitors 67 Imatinib 67 gastrointestinal stromal tumors 67 Elesclomol 67 Carfilzomib 67 Sorafenib 66 Alemtuzumab 66 mTOR inhibitor 66 superficial bladder cancer 66 PARP inhibitor 65 Apixaban 65 tyrosine kinase inhibitor 65 Maraviroc 65 abiraterone 65 malignant pleural mesothelioma 65 Jevtana 65 Voreloxin 65 Advexin 65 MEK inhibitor 65 PLX# 64 Everolimus 64 Hycamtin 64 Torisel 64 ZD# [001] 64 liposomal formulation 64 Cethromycin 64 Avastin bevacizumab 64 Irinotecan 64 phase IIb clinical 64 Rituximab 64 axitinib 64 Diamyd ® 64 Amrubicin 64 tasocitinib 64 Pirfenidone 64 AVE# 63 nucleoside analogue 63 BMS # 63 Varenicline 63 temsirolimus 63 PARP inhibitors 63 Herceptin trastuzumab 63 glioblastoma multiforme GBM 63 bevacizumab Avastin 63 EZN 63 luteinizing hormone releasing 63 R sorafenib tablets 63 CYC# 63 Oxaliplatin 63 Bevacizumab 63 Cladribine 63 Bortezomib 63 SPC# [001] 63 Desmoteplase 63 Phenoxodiol 62 orally bioavailable 62 OncoVEX GM CSF 62 Clevudine 62 EGFR inhibitors 62 anticancer compound 62 riluzole 62 cabazitaxel 62 anticancer therapy 62 Doxorubicin 62 PEG SN# 62 Gemcitabine 62 angiogenesis inhibitors 62 GLPG# 62 selective estrogen receptor 62 Pivotal Phase III 62 bone metastasis 62 BNC# 62 eltrombopag 62 immunomodulator 62 Sym# 62 Ipilimumab 62 Lu AA# 62 Rapamycin 62 KRN# 62 Linaclotide 62 ATL# [001] 62 Perifosine 62 figitumumab 62 LY# [003] 62 Bavituximab 62 experimental hepatitis C 62 organ transplant rejection 62 olmesartan 61 Onalta 61 Yervoy 61 Rivaroxaban